Image For Activity Cover
ORN Summer 2025 - State sequence analysis of daily methadone dispensing trajectories among individuals at United States opioid treatment programs before and following COVID-19 onset
Description:

This lecture will explore how methadone dispensing practices across U.S. opioid treatment programs (OTPs) changed following the COVID-19 regulatory relaxation that expanded eligibility for take-home doses. Using data from a multi-state retrospective chart review, we will examine daily methadone treatment trajectories before and after the policy change, highlighting key drivers of variation, including clinic-level practices and patient characteristics such as methamphetamine use, housing status, and gender. The session will emphasize how institutional decision-making, more than individual clinical factors, shaped access to take-home medication and discuss the implications for equitable and evidence-based care moving forward.

Learning objectives:
At the conclusion of this seminar, attendees should be able to:
  • Analyze individual- and clinic-level factors associated with different medication trajectories in methadone maintenance before and after COVID-19.
  • Analyze individual- and clinic-level factors associated with the allocation of take-home doses once federal regulations were relaxed after the pandemic.
  • Describe the advantages of state sequence analysis as a tool in pharmacoepidemiological research and its potential to analyze data collected in healthcare routinely.
  • Evaluate how disruptive events, such as COVID-19, can be utilized as turning points to change SUD-related policy.

 
CME

Continuing Medical Education (CME) Credits Available

Participants in this program may earn the following CME credits:

✔ 1 AOA Category 1-A Credit

Earn valuable continuing education credits while enhancing your professional knowledge!

Instructions and Claiming CME
Need help claiming your CME certificate? Download the instructions here.
Note:  Video content must be watched in its entirety and surveys must be complete to claim CME certificates. The survey opens in a new browser tab. You must complete the survey and return to the original browser tab, answer the attestation question, then claim your CME.
What is ORN
  • Help is here! The Opioid Response Network (ORN) is your resource for no-cost education, training and consultation to enhance efforts addressing opioid and stimulant use disorders.
  • ORN has consultants in every state and territory to deploy across prevention, treatment, recovery and harm reduction.
  • Share your needs via the “Submit a Request” form at www.OpioidResponseNetwork.org. Within one business day, your regional point person will be in touch to learn more.
Speaker:
Ignacio Borquez, MA

Ignacio Borquez's research focuses on evaluating and designing policies for hidden populations, such as children in foster care; individuals with substance use disorders, severe mental health disorders, or both; or people involved in the criminal justice system. His current work seeks to understand longitudinal patterns of healthcare services usage among patients with substance use disorders and how different trajectories affect later social and health outcomes. Before joining the doctoral program at NYU Grossman School of Medicine, Ignacio worked as a researcher at the Center for Studies on Justice and Society at Pontificia Universidad Católica de Chile and in the Early Psychosis Intervention Program at Horwitz Psychiatric Institute, Chile. He earned his BA and MA in sociology from Pontificia Universidad Católica de Chile.
Noa Krawczyk, PHD

Noa Krawczyk is an assistant professor in the Department of Population Health at NYU Grossman School of Medicine and Associate Director of the NYU Langone Center for Opioid Epidemiology and Policy. Her research focuses on studying ways to address barriers to evidence-based treatment for opioid use disorder at the individual, program, and policy levels. She is also focused on studying new models of care delivery that can improve access, quality, and effectiveness of care, especially among vulnerable groups such as persons with criminal justice involvement. Her work centers on bridging research and practice by collaborating with drug user organizations, health system leaders, public health and government agencies, and advancing science that can help inform evidence-based policies and practices that reduce harm and promote well being. Prior to her current position, Dr. Krawczyk completed her PhD at the Johns Hopkins Bloomberg School of Public Health, where she studied substance use epidemiology, and previously worked as a Fulbright research scholar to study substance use treatment and health services in Brazil.
DISCLAIMER
ACCREDITATION: 
In support of improving patient care, American Academy of Addiction Psychiatry is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

DISCLOSURE AND CONFLICT OF INTEREST RESOLUTION:
All conflicts of interest of any individual(s) in a position to control the content of this CME activity will be identified and resolved prior to this educational activity being provided. Disclosure about provider and faculty relationships, or the lack thereof, will be provided to learners.
Funding:
Funding for this initiative was made possible (in part) by grant no. 1H79TI088037 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.
Summary
Availability:
Registration Required
Access expires on Aug 01, 2028
Location:
Online Meeting
Date / Time:
Sep 03, 2025 5:00 PM - 6:00 PM ET
Cost:
FREE
Credit Offered:
1 AOA Category 1A Credit
Recommended
Powered By